Nachrichten zur Aethlon Medical Inc. Aktie

By M. MarinNASDAQ: AEMDREAD THE FULL AEMD RESEARCH REPORTEarly observations from 1st two cohorts showed consistent improvements in immune functionAethlon…

…

By M. MarinNASDAQ: AEMDREAD THE FULL AEMD RESEARCH REPORTMoving to final dosing cohort brings AEMD closer to generating, reporting data…

…

Image source: The Motley Fool.DATEJune 10, 2026, 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer and Chief Financial Officer — James FrakesChief…

By M. MarinNASDAQ: AEMDREAD THE FULL AEMD RESEARCH REPORTDSMB recommends AEMD progress clinical trial to the final third cohortAethlon Medical…

NASDAQ: AEMDLili Elston: Hello, and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host,…

By M. MarinNASDAQ: AEMDREAD THE FULL AEMD RESEARCH REPORTCompany’s current strategic focus is assessing the Hemopurifier in oncology…We participated in…

By M. MarinNASDAQ:AEMDREAD THE FULL AEMD RESEARCH REPORTCohort 2 participants being treated, with queue building for patient participation in trialAethlon…

Aethlon Medical stock falls after $3.3M private placement…

Aethlon Medical stellte am 26.06.2025 die jüngste Quartalsbilanz zum am 31.03.2025 abgelaufenen Quartal vor.Es wurde ein Verlust je Aktie in…

…

…

…